Renaissance Technologies (RenTech)'s ARKG Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 67,700 shares of ARK Genomic Revolution ETF (ARKG) worth $1.96 M, representing 0.00% of the portfolio. First purchased in 2021-Q4, this short-term holding has been held for 7 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in ARKG for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 83,300 shares. Largest reduction occurred in Q2 2022, reducing 57,600 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s ARK Genomic Revolution ETF (ARKG) Holding Value Over Time
Track share changes against reported price movement
Quarterly ARK Genomic Revolution ETF (ARKG) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -15,600 | Reduce 18.73% | 67,700 | $28.97 |
| Q3 2025 | +83,300 | New Buy | 83,300 | $27.77 |
| Q4 2022 | -17,800 | Sold Out | 0 | $0.00 |
| Q3 2022 | +17,800 | New Buy | 17,800 | $32.87 |
| Q2 2022 | -57,600 | Sold Out | 0 | $0.00 |
| Q1 2022 | +16,200 | Add 39.13% | 57,600 | $45.94 |
| Q4 2021 | +41,400 | New Buy | 41,400 | $61.23 |
Renaissance Technologies (RenTech)'s ARK Genomic Revolution ETF Investment FAQs
Renaissance Technologies (RenTech) first purchased ARK Genomic Revolution ETF (ARKG) in Q4 2021, acquiring 41,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held ARK Genomic Revolution ETF (ARKG) for 7 quarters since Q4 2021.
Renaissance Technologies (RenTech)'s largest addition to ARK Genomic Revolution ETF (ARKG) was in Q3 2025, adding 83,300 shares worth $2.31 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 67,700 shares of ARK Genomic Revolution ETF (ARKG), valued at approximately $1.96 M.
As of the Q4 2025 filing, ARK Genomic Revolution ETF (ARKG) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in ARK Genomic Revolution ETF (ARKG) was 83,300 shares, as reported at the end of Q3 2025.